試す 金 - 無料
Banks bet on personal loans despite signs of rising stress
Mint New Delhi
|February 13, 2025
Lenders to expand high-yield portfolio even as growth slows; focus on salary account holders

Indian banks turned cautious on personal loans after the regulator's warnings and rising stress in collateral-free advances and microloans, slowing growth in one of their fastest-growing segments. Yet, far from giving up on it, they continue to bet on such lending to grow.
Most lenders, in their third-quarter earnings calls, guided that while growth may have slowed for a quarter or two, a majority of their customers continue to pay on time. They will continue to expand the portfolio in the coming quarters given that the bulk of the exposure is to salaried account holders and overall portfolio quality remains robust.
While the banking sector, including State Bank of India, has seen some slowdown in this segment, the lender's portfolio is different because the bank typically only lends to salaried customers that have accounts with SBI, said CS Setty, chairman of India's largest lender by assets, at the Q3 earnings conference.
"Our (unsecured personal loan) portfolio is showing good growth in the current quarter, which means that whatever lower growth we had in the last three quarters, we were able to reverse that," Setty said, adding that while the earlier levels of 30-32% compound annual growth rate (CAGR) may not be possible, it will "definitely come back to double digits".
このストーリーは、Mint New Delhi の February 13, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Mint New Delhi からのその他のストーリー

Mint New Delhi
How CCI plans to watch AI use by companies
The Competition Commission of India (CCI) on Monday proposed a self-audit for companies to keep track of how they use artificial intelligence (AI) and the data they train AI models on. Implementing such a practice comes with multiple caveats. Mint explains.
2 mins
October 08, 2025

Mint New Delhi
NAVIGATING A JOB LOSS IS NOT AS HARD AS IT SEEMS, BUT YOU SHOULD START EARLY
The best time to mend the roof is when the sun is shining, not after the rains commence. There is so much wisdom in this one sentence that it needs careful reflection. People expect life to be a smooth, sedate, upward ride, but it is anything but that. In fact, every facet of life has its ups and downs - sometimes, they are positive and at other times, they may be challenging.
3 mins
October 08, 2025
Mint New Delhi
US TARIFF-LED RISKS PERSIST FOR INDIA
The Indian economy stumbled in August, hit by the US's additional 25% tariffs on top of the 25% reciprocal levy, as external risks weighed on domestic momentum through a weakening rupee, continued selling by foreign investors, sliding stock market and slowing exports.
3 mins
October 08, 2025
Mint New Delhi
Nykaa fashion arm sashays again—spotlight on the stride
The fashion business of FSN E-Commerce Ventures Ltd (Nykaa) is showing signs of revival after several quarters of modest performance.
1 mins
October 08, 2025

Mint New Delhi
‘RBI focusing on new use cases for e-rupee’
The Reserve Bank of India (RBI) is in no rush to open up the pilots for the central bank digital currency (CBDC) to the masses and is, instead, focusing on adding more use cases to the e-rupee with a focus on cross-border transactions, T. Rabi Sankar, deputy governor of the central bank, said on Tuesday.
1 mins
October 08, 2025
Mint New Delhi
Nobel physics prize goes to pioneers of quantum mechanics
US-based scientists John Clarke, Michel Devoret and John Martinis won the 2025 Nobel Prize in Physics for “experiments that revealed quantum physics in action”, paving the way for the development of the next generation of digital technologies.
1 min
October 08, 2025
Mint New Delhi
Nvidia to continue sponsoring H-1B visas
Chipmaker Nvidia's CEO Jensen Huang said that the company will continue to sponsor H-IB visas and cover all associated costs following U.S. President Donald Trump's executive order last month that imposed a $100,000 fee on each new application, Business Insider reported on Tuesday.
1 min
October 08, 2025
Mint New Delhi
AstraZeneca to sell cancer drug in India
AstraZeneca Pharma on Tuesday said it has received approval from the national drug regulator to market a cancer treatment drug in the country.
1 min
October 08, 2025
Mint New Delhi
Fintech lending growth slows after clampdown
But delinquency and deep-stage stress are still elevated, shows report
2 mins
October 08, 2025
Mint New Delhi
CENTRAL BANK OF INDIA RATED INDIA INVOLVED BY SKOCH FOR TRANSFORMING RECRUITMENT ONBOARDING DIGITALLY
The Central Bank of India has undertaken a landmark initiative to reimagine its recruitment and onboarding practices through a comprehensive digital solution.
1 mins
October 08, 2025
Listen
Translate
Change font size